Fivetran Launches Hybrid Deployment, Enabling Enterprises to Run Pipelines in Any Environment on a Unified Platform
18.9.2024 10:00:00 CEST | Business Wire | Press release
Hybrid Deployment offers a secure, flexible solution for seamless data movement across environments
Fivetran, the global leader in data movement, today announced Hybrid Deployment, a new solution that allows customers to securely run data pipelines within their own environment from the Fivetran managed platform, providing a single control plane to manage all data sources, whether they are cloud-based SaaS apps or legacy databases with data that needs to be tightly controlled and managed for regulatory or compliance purposes. With the industry’s most comprehensive selection of connectors, destinations and features, Fivetran empowers enterprises to centralize data efficiently, reliably and securely, while supporting governance and compliance requirements and benefiting from 24/7 support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240918100338/en/
Introducing Fivetran’s Hybrid Deployment: A fully managed service that meets the highest enterprise security standards. (Graphic: Business Wire)
Enterprises with sensitive data or in regulated industries often struggle to build data-driven practices. Seamless data access is critical for boosting efficiency, enabling AI-powered analytics and producing reliable data products. Centralizing data can lead to complex, costly systems that burden engineering teams. Traditional SaaS tools often lack the needed control and security, forcing organizations into more cumbersome solutions. DIY or self-hosted solutions often fail to scale effectively, especially as data priorities evolve in the age of AI, resulting in inefficiencies and an urgent need for modernization. Fivetran’s Hybrid Deployment simplifies this by enabling businesses to securely centralize their data and prepare it for AI and machine learning, all while maintaining control over sensitive information.
"Introducing a hybrid cloud deployment model to the Fivetran platform opens up entirely new possibilities for businesses of all sizes," said George Fraser, Fivetran CEO. "Businesses no longer have to choose between managed automation and data control. They can now securely move data from all their critical sources—like Salesforce, Workday, Oracle, SAP, other cloud and on-premises databases and ERPs—into a data warehouse or data lake, all while keeping that data under their own control. This is especially valuable for industries like healthcare and life sciences and financial services, where secure, compliant and reliable data is critical."
How Hybrid Deployment works
Hybrid Deployment keeps sensitive data within the customer’s environment while taking advantage of Fivetran’s management and monitoring tools. A lightweight local connector securely moves the data, while Fivetran’s user-friendly interface makes configuration and monitoring simple, all from a single control plane.
"Fivetran's new hybrid deployment option is a game-changer. Now customers can easily centralize all their data, regardless of security or compliance requirements, given the ability to separate the control and data plane,” said Vinay Kumar Katta, Managing Delivery Architect, Capgemini. “Customers will appreciate Fivetran's best-in-class platform that offers the flexibility to choose how and where their pipelines run. We're excited to advance our partnership with Fivetran and help more enterprises modernize their data infrastructure."
The separate control and data plane architecture ensures data never leaves the customer’s secure environment, giving them ultimate control over how their data is moved while still benefiting from Fivetran’s managed platform. This solution automates and centralizes the data movement process, while also giving enterprises the benefits of:
- Full visibility: Monitor all pipelines from a single interface.
- Data security: Control access, mask sensitive data and track movement to ensure compliance.
- Compatibility across environments: Works across AWS, Microsoft Azure, Google Cloud, and on-premises environments.
- Simple setup: Quick installation with no complex maintenance required.
- Flexibility: Scale and customize pipelines with integrations for APIs and tools like Terraform.
- Cost management: Track usage and control budgets with detailed reporting tools.
"phData is excited about Fivetran's new Hybrid Deployment option, which allows our customers in regulated industries like healthcare, life sciences and financial services to scale the configuration and ingestion of highly sensitive datasets on self-managed infrastructure," said Troy Fokken, Chief Architect at phData. "This approach streamlines the data pipeline processes, as customers don't need to self-host software or build DIY pipelines to securely move data from source systems to destination."
As government regulations like GDPR, HIPAA and CCPA continue to tighten, and new ones emerge, enterprises are increasingly focused on ensuring their data practices meet strict security and compliance standards. Recent breaches in healthcare and financial services have highlighted the risks of exposing sensitive information and compromising critical systems. DIY or self-managed pipelines can introduce vulnerabilities, especially as teams must frequently make updates in order to meet rapidly changing data schema, which increases the risk of errors that can lead to data breaches. Fivetran’s Hybrid Deployment mitigates these risks by providing a managed solution that runs within the customer’s secure environment, ensuring compliance while eliminating common points of failure.
“The simplicity of management is the best value of Hybrid Deployment,” said Ajay Bidani, Data and Insights Manager at Powell Industries. “I know the status of our pipelines and can launch and manage cloud-based and on-premises pipelines directly from one platform. Given our history with on-premises applications, I can say that pipelines going down and requiring restart was quite cumbersome, but Hybrid Deployment has been considerably different. I can realize the ease of monitoring and maintaining pipelines with immediacy. The ability to quickly stand up Hybrid Deployment for on-premises data movement, while managing it from a straightforward and familiar cloud-based control plane, is a great value add.”
Reducing complexity for engineering teams
Hybrid Deployment reduces manual setup and maintenance, allowing engineering teams to focus on building data-driven solutions. Fivetran handles the heavy lifting, helping businesses extract value from their data without worrying about brittle DIY infrastructure. A recent report by IDC found that enterprises can realize an average annual productivity gain of $1.5 million by transitioning to Fivetran’s managed data movement solution.
Fivetran’s data integration platform can handle high-volume change data capture from databases and offers 600+ pre-built connectors for a range of SaaS applications, events, files, ERPs, data warehouses and data lakes. The Fivetran platform replicates data with minimal impact on source systems, low latency and high throughput, making it the trusted choice for over 6,300 customers globally. With the richest technical feature set of any data ingestion tool, Fivetran meets the widest range of data integration use cases.
To learn more, visit the Fivetran blog or explore images and assets in the Fivetran newsroom. You can also start your free Hybrid Deployment trial today at Fivetran.com.
About Fivetran
Fivetran, the global leader in data movement, helps customers use their data to power everything from AI applications and ML models, to predictive analytics and operational workloads. The Fivetran platform reliably and securely centralizes data from hundreds of SaaS applications and databases into any cloud destination — whether deployed on-premises, in the cloud or in a hybrid environment. Thousands of global brands, including Autodesk, Condé Nast, JetBlue and Morgan Stanley, trust Fivetran to move their most valuable data assets to fuel analytics, drive operational efficiencies and power innovation. For more info, visit fivetran.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240918100338/en/
Contacts
Matias Cavallin
Matias Cavallin
323-715-0020
matias.cavallin@fivetran.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom